Skip to main content

Table 1 Summary of the treatment planning objectives and the radiobiological parameters used in the evaluation

From: Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy – applied to prostate proton treatments

ROI   α/β
CTV N/A 1.5
PTV Minimise V(D<33.0 Gy) N/A
  Minimise V(D>34.7 Gy)  
Rectum Minimise V(D>29.6 Gy) 3.0
Bladder Minimise V(D>29.6 Gy) 3.0